Leukos Biotech

About:

Leukos Biotech is a biopharmaceutical company

Website: http://www.leukosbiotech.com

Top Investors: Inveready, EASME - EU Executive Agency for SMEs, ICF Capital

Description:

Leukos Biotech is a biopharmaceutical company focused on the development of new treatments for Acute Myeloid Leukaemia and other haematological malignancies. The company was founded in 2015 as a spin-off from the Josep Carreras Leukaemia Research Institute (IJC) and has a strong scientific, institutional and economic support from the IJC and the Josep Carreras Leukaemia Foundation, among other partners and collaborators.

Total Funding Amount:

3.77M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2015-01-01

Founders:

Ruth Risueño

Number of Employees:

1-10

Last Funding Date:

2019-04-01

IPO Status:

Private

Industries: